References
Faivre S, Djelloul S, Raymond E (2006) New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin Oncol 33(4):407–420
Lord CJ, Ashworth A (2010) Biology-driven cancer drug development: back to the future. BMC Biol 8:38
Rowinsky EK (2003) Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies. Clin Oncol 21(10 Suppl):175s–186s
See Also
(2012) Bioinformatics. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, pp 403–404. doi: 10.1007/978-3-642-16483-5_631
(2012) Biologically effective dose. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 404. doi: 10.1007/978-3-642-16483-5_638
(2012) Biomarkers. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, pp 408–409. doi: 10.1007/978-3-642-16483-5_6601
(2012) Chemoresistance. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 790. doi: 10.1007/978-3-642-16483-5_1076
(2012) Dasatinib. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 1060. doi: 10.1007/978-3-642-16483-5_1518
(2012) Humanized monoclonal antibody. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 1760. doi: 10.1007/978-3-642-16483-5_6844
(2012) Maximum tolerable dose. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 2188. doi: 10.1007/978-3-642-16483-5_3566
(2012) Monoclonal antibody therapy. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, pp 2367–2368. doi: 10.1007/978-3-642-16483-5_3823
(2012) Personalized medicine. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 2828. doi: 10.1007/978-3-642-16483-5_4476
(2012) Pharmacodynamics. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 2840. doi: 10.1007/978-3-642-16483-5_4495
(2012) Pharmacokinetics. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 2845. doi: 10.1007/978-3-642-16483-5_4500
(2012) Philadelphia chromosome. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 2864. doi: 10.1007/978-3-642-16483-5_4520
(2012) Systems biology. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 3598. doi: 10.1007/978-3-642-16483-5_5643
(2012) Tyrosine kinase. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 3822. doi: 10.1007/978-3-642-16483-5_6079
(2012) Xenograft. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer Berlin Heidelberg, p 3967. doi: 10.1007/978-3-642-16483-5_6278
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Duhé, R.J. (2014). Drug Design. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_1735-3
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_1735-3
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences